Research Article
Protective Effect of Flos Lonicerae against Experimental Gastric Ulcers in Rats: Mechanisms of Antioxidant and Anti-Inflammatory Action
Table 1
Antiulcerogenic activities of GC-7101 for acute and subchronic gastric ulcers.
| | Experimental models | Treatment | Dose | Gastric lesion | Inhibition (%) |
| | HCl/EtOH | Vehicle | — | 81.8 ± 12.0 | — | | Ranitidine | 30 | 40.3 ± 7.9 | 50.7 | | Rebamipide | 30 | 35.0 ± 8.3 | 57.2 | | GC-7101 | 25 | 40.5 ± 6.8 | 50.5 | | 50 | 32.8 ± 4.4 | 60.0 | | 100 | 41.9 ± 8.4 | 48.8 |
| | Indomethacin | Vehicle | — | 35.6 ± 5.3 | — | | Ranitidine | 30 | 3.6 ± 0.9 | 89.8 | | Rebamipide | 30 | 12.0 ± 2.1 | 66.4 | | GC-7101 | 25 | 13.1 ± 2.1 | 63.3 | | 50 | 12.0 ± 2.1 | 66.4 | | 100 | 9.6 ± 4.9 | 72.9 |
| | Water immersion restraint stress | Vehicle | — | 21.1 ± 2.1 | — | | Ranitidine | 30 | 7.5 ± 1.1 | 64.4 | | Rebamipide | 30 | 13.4 ± 1.5 | 36.6 | | GC-7101 | 25 | 10.9 ± 1.4 | 48.3 | | 50 | 8.4 ± 1.1 | 60.2 | | 100 | 8.3 ± 1.5 | 60.6 |
| | Acetic acid | Vehicle | — | 20.0 ± 1.5 | — | | Ranitidine | 30 | 10.3 ± 1.1 | 48.4 | | Rebamipide | 30 | 8.4 ± 1.5 | 57.7 | | GC-7101 | 25 | 8.9 ± 1.7 | 55.6 | | 50 | 8.5 ± 1.9 | 57.6 | | 100 | 5.3 ± 0.8 | 73.7 |
|
|
The values are represented as means ± SEM for eight to ten rats per group. Significantly different (P < 0.05, P < 0.01) from vehicle-treated rats.
|